Significance {#s1}
============

There is a growing interest in circRNAs due to their implication in many biological processes and diseases in addition to their biomarker potential. They are mainly detected by the presence of reads mapping their backsplicing junction. Nevertheless, circRNAs are no longer the only transcripts containing such a junction since recent studies have revealed that circular DNAs are common and can be transcribed resulting in transcripts that would mimic a circRNA signal. Therefore, this new type of chimeric transcript can change the way in which circRNA analysis is being done and impact some of the results already reported.

Are Circular RNAs the Only Chimeric Transcripts? {#s2}
================================================

Circular RNA (circRNAs) were rediscovered a few years ago as non-canonically spliced RNA forms present in different organisms including humans ([@B39]; [@B19]). They are covalently closed transcripts formed through an RNA back-splicing event, where a splice donor of a downstream exon joins to an upstream splice acceptor leading to covalently closed transcripts that are characterized by the presence of a back-splicing junction that makes circRNAs distinguishable from their linear counterparts ([**Figure 1A**](#f1){ref-type="fig"}) ([@B49]; [@B47]).

![Detection of both circular RNA and DNAs is based on reads spanning the junction. **(A)** Backspliced joining between exons and canonical exon joining are depicted with non-continuous and continuous lines respectively giving rise to circRNAs and mRNAs. Paired-end reads spanning the backspliced junctions are shown in red and paired-end reads consistent with a linear transcript are shown in blue. **(B)** Similar to circRNAs, circular DNAs (eccDNAs) are detected based on structural-read variants consistent with a circularization event depicted in red \[adapted from ([@B34])\].](fgene-10-00940-g001){#f1}

Since their rediscovery, the scientific community has drawn its attention to circRNAs and has investigated their involvement in several cellular processes in health and disease ([@B16]), their potential role as biomarkers ([@B1]), and their regulatory functions ([@B11]). CircRNAs are now known to be abundant and stable in the cytosol and the nucleus ([@B39]; [@B19]; [@B27]) and have also been found free in biofluids ([@B6]; [@B32]; [@B9]) and in extracellular vesicles ([@B22]). The biomarker potential of circRNAs has been intensely studied, in fact, there have been published many case-control studies seeking for differentially expressed circRNAs that could be biomarkers of different diseases. To date, circRNAs have been implicated in several diseases including cancer ([@B20]; [@B3]), neurological disorders ([@B2]), cardiovascular diseases ([@B5]) and immune-related diseases ([@B17]; [@B28]). At the same time, getting to fully understand their biogenesis, characteristics, functions, and implications in human biology remain as open questions for researchers in the field.

Although the function of most of the circRNAs remains unknown, it has been shown that some circRNAs can act as microRNA sponges, regulating the microRNA levels and their activity ([@B14]; [@B31]; [@B50]). They are involved in gene expression regulation by regulating the transcription of their parental genes, competing with the linear splicing or sponging proteins (Ashwal-Fluss et al., 2014; Li et al., 2018). Interestingly, ribosome profiling studies have recently shown that circRNAs can also be translated both *in vitro* and *in vivo* ([@B23]; [@B48]).

The main feature of circRNAs, and responsible for most of their special properties, is their circularity. Therefore, besides detecting their characteristic back-spliced junction, testing the circularity of these molecules, is one of the key points in every circRNA study. Nevertheless, many studies have based their discovery of circRNAs on total RNA and might thereby have interpreted some linear chimeric transcripts as circRNAs, resulting in false positive circRNA detections. To circumvent this problem most studies have confirmed the circularity of the transcripts found by total RNA-seq using RNase R, Northern blot or electrophoretic methods ([@B18]). However, these circularity validations have also sometimes revealed transcripts that seem to be linear, rather than circular confirming that the detection of circRNAs starting from total RNA can lead to some false positives. These false positives have been attributed to technical artifacts or transcripts derived from uncommon events such as exon duplications or transplicing events ([@B18]; [@B43]). That said, the option of having found true, biologically active and functional linear transcripts that contain a sequence equivalent to a backsplicing junction (from now on called chimeric linear transcripts), has been somewhat overlooked because a source of such linear RNA has not been known for healthy cells.

Circular DNAs as a Source of Chimeric Linear Transcripts {#s3}
========================================================

Most of the human genome is organized in linear chromosomes, however, some exceptions have long been accepted such as mitochondrial DNA, and chromosomal aberrations such as DNA circles carrying oncogenes (e.g. double minutes) ([@B7]; [@B36]; [@B45]) and ring chromosomes ([@B44]). It was not until recently that different circular DNAs such as microDNAs ([@B40]) or extrachromosomal circular DNAs (eccDNAs) were found to also arise from large parts of different eukaryotic genomes including human and yeast ([@B35]; [@B21]; [@B34]).

Circular DNAs are formed when two ends of a linear DNA are joint together resulting in a junction similar to the backspliced junction on circRNAs commonly called breakpoint junction that is detected based on structural-read variants consistent with a circularization event ([@B12]; [@B34]; [@B38]) ([**Figure 1B**](#f1){ref-type="fig"}). They usually range from a hundred bases to megabase circles and can contain full exons and genes ([@B40]; [@B35]; [@B21]; [@B45]; [@B34]) and while some regions of the genome are more commonly found on circular DNA ([@B41]; ; [@B33]; [@B45]; [@B34]), most circular DNA appear to occur at random ([@B40]; [@B35]; [@B21]; [@B34]).

Interestingly, in a recent paper Møller et al. identified thousands of eccDNAs in leucocytes and muscle cells in healthy controls. With the idea of investigating whether eccDNAs could be transcribed, an mRNA library was also sequenced from muscle tissue and analyzed for transcription events across the breakpoint junction of the detected eccDNA finding several matches ([@B34]). This finding suggests that circular DNA in healthy tissue is transcribed, giving rise to linear and polyadenylated transcripts that will carry a sequence equivalent to the backsplicing sequence of circRNAs ([@B34]) ([**Figure 2**](#f2){ref-type="fig"}).

![Graphical representation of different transcripts arised from either genomic DNA or circular DNA. Exons are colored in purple and the backspliced junctions or chimeric junctions are shown in red. Polyadenylated, chimeric junction containing and RNase R resistant transcripts are highlighted in orange, blue and yellow respectively.](fgene-10-00940-g002){#f2}

The transcriptional evidence of circular DNAs, together with their abundance, lead us to suggest that circular DNAs could be a natural source of a substantial amount of linear RNAs carrying chimeric junctions. In many cases, these chimeric junctions might be indistinguishable from the backsplicing junctions of circRNAs, and therefore they might be confounding factors in circRNA studies. In the following paragraphs, we will explain the data supporting this proposal.

circRNA Detection: All That Glitters Is Not Gold {#s4}
================================================

As previously introduced, circRNAs are formed though a non-canonical splicing event called backsplicing. Transcripts resulting from this backsplicing event have a covalently closed loop structure with neither 5′--3′ polarity, nor a polyadenylated tail and more importantly, they are characterized by the presence of a scrambled exon order relative to the linear transcript ([@B49]; [@B47]). This scrambled exon order becomes evident in the backspliced junction that connects a 5' downstream sequence with an upstream 3' sequence. Thus, all the circRNA detection algorithms exploit the presence of the back-spliced junctions as a diagnostic feature for the identification of circRNA ([**Figure 1A**](#f1){ref-type="fig"}).

Different methods have been adapted for the detection of these back-spliced junctions. Commercial arrays containing probes targeting these backspliced regions have been widely used in biomarker screening studies ([@B17]; [@B29]; [@B42]; [@B26]). The subsequent validation is often also based on the amplification of the backsplicing junctions using divergent primers ([@B37]). Many other papers have conducted a high throughput sequencing analysis that overcomes one of the main limitations of the arrays allowing to detect not only the annotated circRNAs but also *de novo* RNA circularization events from genomic regions where no circRNA were annotated by previous studies. Several bioinformatic pipelines have been developed for the detection of circRNAs in RNA-Seq datasets, but all of them are based on the presence of reads crossing over the back-splicing junctions and finding the most reliable one is still a challenge for bioinformaticians ([@B15]; [@B13]; [@B38]).

Two main approaches can be followed for the detection of circRNAs in RNA-Seq data. Firstly, many circRNA RNA-seq studies are based on RNase R treated samples in order to deplete all the linear RNAs before sequencing. Although this approach is specially designed for the circRNA detection it is worth noting that RNase R degradation is variable, that there are rare cases of RNase R resistant linear RNAs and RNase R sensitive circRNAs ([@B43]) and that this treatment requires a high RNA input which could be limiting for some tissues. Other circRNA studies choose to sequence either total, ribosomal-depleted (ribo-), or non-polyadenylated (polyA-) RNA, where both linear and circular RNAs can be found ([@B39]; [@B31]; [@B8]; [@B30]; [@B32]). This approach avoids the use of RNase R, which reduces the RNA amount needed for the sequencing and allows studying the expression of other types of RNAs from the same dataset. It has been demonstrated that with a good sequencing depth and quality and a carefully data-analysis, true circRNAs can be detected from total RNA sequencing ([@B46]), however, in this second approach, a later circularity confirmation for circRNAs is needed.

With the discovery of linear chimeric RNAs transcribed from circular DNAs, circRNAs are no longer the only transcripts with chimeric junctions. Therefore, it is of utmost importance to note that whereas the first approach will significantly enrich the RNA sample in circRNAs so that most of the detected chimeric junctions will correspond to true circRNAs, the second one might overestimate the number of circRNA transcripts by attributing to circRNAs the signal coming from both circRNAs and the linear chimeric transcripts transcribed from circular DNAs. Consequently, taking into account the coexistence of circRNAs and linear chimeric transcripts, the need of circularity tests and functionality assays gains importance and special care should be taken regarding not only experimental but also computational methods to avoid mistaking chimeric transcripts from circular DNAs with circRNAs formed by backsplicing.

Discussion {#s5}
==========

The circRNA field is still at an early stage, however, circRNAs have already shown to be astonishing molecules, implicated in many processes, with a great biomarker potential and that can also change the way we understand the transcription and translation processes. For these reasons, they are gaining attention and the circRNA field is at the moment one of the most active RNA research fields. However, there are still many conflicts, controversies and open questions ([@B24]) that have to be discussed.

In this report, and in light of the recent advances in the circular DNA field, we want to point out the transcription from extrachromosomal circular DNA as one of the main natural sources of linear transcripts with back-spliced signals that could be interfering with circRNA data ([@B34]). From now on, apart from the technical artifacts, duplications and transplicing events that could lead to false positives in the circRNA detection, we should take also into account the existence of this new type of chimeric transcripts. Therefore circularization tests and functional assays are more important than ever.

In any case, these chimeric linear transcripts should not only be considered as a mere confounding factor for circRNA studies. Despite the technical implications for the circRNA characterization, the existence of these circRNA-like chimeric linear RNA molecules coming from eccDNAs adds a new type of molecule to the ever-growing list of RNAs and expands our vision about the complexity of the transcriptome and its regulation. Moreover, these linear RNA molecules coming from eccDNA could also present functions similar to the circRNA, including the regulatory functions or the potential to be translated. Gene products from eccDNA transcripts could potentially contribute to the phenotype of somatic cells and tissue as reported in yeast ([@B12]; [@B10]). However in this nascent field, more data and research is needed to start scratching the surface of the iceberg.
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